Cancer Letters
Volume 230, Issue 2 , Pages 271-283 , 18 December 2005

5-Aza-2′-deoxycytidine induces retinoic acid receptor-β2 demethylation and growth inhibition in esophageal squamous carcinoma cells

  • Zhongmin Liu

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
    • ,
  • Liyong Zhang

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
    • MOE Key Laboratory of Bioinformatics, Institute of Bioinformatics, Department of Automation, Tsinghua University, Beijing 100084, Peoples Republic of China
    • ,
  • Fang Ding

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
    • ,
  • Jie Li

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
    • ,
  • Mingzhou Guo

      Affiliations

    • Division of Tumor Biology, Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA
    • ,
  • Wendong Li

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
    • ,
  • Yunhai Wang

      Affiliations

    • Department of Thoracic Surgery, the First Affiliate Hospital of Anhui Medical University, Hefei 230022, Peoples Republic of China
    • ,
  • Zaicheng Yu

      Affiliations

    • Department of Thoracic Surgery, the First Affiliate Hospital of Anhui Medical University, Hefei 230022, Peoples Republic of China
    • ,
  • Qimin Zhan

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
    • ,
  • Min Wu

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
    • ,
  • Zhihua Liu

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
    • Corresponding Author InformationCorresponding author. Tel./fax: +86 10 67723789.

Received 27 September 2004 ,Revised 7 January 2005 ,Accepted 10 January 2005.

References 

  1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer. 1993;54(4):594–606
  2. Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int. J. Cancer. 1996;69:225–235
  3. Oka M, Yamamoto K, Takahashi M, Hakozaki M, Abe T, Iizuka N, et al. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res. 1996;56:2776–2780
  4. Wu M, Hu N, Wang XQ. In:  Lynch HT,  Hirayama T editor. Genetic factor in the etiology of esophageal cancer and the strategy of its prevention in high-incidence areas of North China. Genetic Epidemiology for Cancer. 270:Boca Raton, FL: CRC Press Inc; 1995;p. 17702–17711
  5. Hu N, Dawsey SM, Wu M, Taylor PR. Family history of oesophageal cancer in Shanxi Province China. Eur. J. Cancer. 1991;27:1336
  6. Hu N, Dawsey SM, Wu M, Bonney GE, He LJ, Han XY, et al. Familial aggregation of esophageal cancer in Yangcheng County,Shanxi Province, China. Int. J. Epidemiol. 1992;21:877–882
  7. Zhang W, Bailey-Wilson JE, Li W, Wang X, Zhang C, Mao X, et al. Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China. Am. J. Hum. Genet. 2000;67(1):110–119
  8. Li G, Hu N, Goldstein AM, Tang ZZ, Roth MJ, Wang QH, et al. Allelic loss on chromosome bands 13q11–q13 in esophageal squamous cell carcinoma. Genes Chromosomes Cancer (Phila). 2001;31:390–397
  9. Evans TRJ, Kaye SB. Retinoids: present role and future potential. Br. J. Cancer. 1999;80:1–8
  10. Chambon P. A decade of molecular biology of retinoic acid receptors. Fed. Am. Soc. Exp. Biol. J. 1996;10:940–954
  11. Collins SJ, Robertson KA, Muller L. Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RARα). Mol. Cell Biol. 1990;10:2154–2163
  12. Xu XC, Lotan R. Aberrant expression and function of retinoic acid receptors in cancer. In:  Nau H,  Blaner WS editor. Handbook of Experimental Pharmacology: Retinoids. Berlin: Springerverlag; 1999;p. 323–324
  13. Qiu H, Zhang W, El-Naggar AK, Lippman SM, Lin P, Lotan R, et al. Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis. Am. J. Pathol. 1999;155:1519–1523
  14. Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, et al. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res. 1997;57:4992–4996
  15. Yang Q, Mori I, Shan L, Nakamura M, Nakamura Y, Utsunomiya H, et al. Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer. Am. J. Pathol. 2001;158:299–303
  16. Qiu H, Lotan R, Lippman SM, Xu XC. Lack of correlation between expression of retinoic acid receptor-beta and loss of heterozygosity on chromosome band 3p24 in esophageal cancer. Genes Chromosomes Cancer. 2000;28:196–202
  17. Tanaka H, Shimada Y, Imamura M, Shibagaki I, Ishizaki K. Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines. Int. J. Cancer. 1997;70:437–442
  18. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer. 1992;69(2):277–284
  19. Shimada Y, Imamura M. Prognostic significance of cell culture in carcinoma of the oesophagus. Br. J. Surg. 1993;80(5):605–607
  20. Kanda Y, Nishiyama Y, Shimada Y, Imamura M, Nomura H, Hiai H, et al. Analysis of gene amplification and overexpression in human esophageal-carcinoma cell lines. Int. J. Cancer. 1994;58(2):291–297
  21. Tanaka H, Shibagaki I, Shimada Y, Wagata T, Imamura M, Ishizaki K. Characterization of p53 gene mutations in esophageal squamous cell carcinoma cell lines: increased frequency and different spectrum of mutations from primary tumors. Int. J. Cancer. 1996;65(3):372–376
  22. Han YL, Wei F, Xu X, Cai Y, Cheng B, Wang J, et al. Establishment and comparative genomic hybridization analysis of human esophageal carcinoma cell line EC9706. Chin. J. Med. Genet. 2002;19:455–457
  23. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989;
  24. Yang Q, Mori I, Shan L, Nakamura M, Nakamura Y, Utsunomiya H, et al. Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer. Am. J. Pathol. 2001;158:299–303
  25. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA. 1996;93:9821–9826
  26. Widschwendter M, Berger J, Hermann M, Muller HM, Amberger A, Zeschnigk M, et al. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J. Natl Cancer. Inst. 2000;92:826–832
  27. Ivanova T, Petrenko A, Gritsko T, Vinokourova S, Eshilev E, Kobzeva V, et al. Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer. BMC Cancer. 2002;2:4
  28. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res. 1999;59:2477–2483
  29. Liu G, Wu M, Levi G, Ferrari N. Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression. Int. J. Cancer. 1998;78:248–254
  30. Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, et al. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res. 2003;63:3724–3728
  31. Bartsch D, Boye B, Baust C, zur Hausen H, Schwarz E. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J. 1992;11:2283–2291
  32. Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 1991;51:3972–3981
  33. Arapshian A, Kuppumbatti YS, Mira-y-Lopez R. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells. Oncogene. 2000;19:4066–4070
  34. Cote S, Sinnett D, Momparler RL. Demethylation by 5-aza-2′-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells. Anticancer Drugs. 1998;9:743–750
  35. Nakayama T, Watanabe M, Yamanaka M, Hirokawa Y, Suzuki H, Ito H, et al. The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in human prostate cancers. Lab Invest. 2001;81:1049–1057
  36. Ogasawara S, Maesawa C, Tamura G, Satodate R. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res. 1995;55:891–894
  37. Lee MO, Kang HJ. Role of coactivators and corepressors in the induction of the RARβ gene in human colon cancer cells. Biol. Pham. Bull. 2002;25:1298–1302
  38. Lin B, Chen GQ, Xiao D, Kolluri SK, Cao X, Su H, et al. Orphan receptor COUP-TF is required for induction of retinoic acid receptor beta, growth inhibition, and apoptosis by retinoic acid in cancer cells, Mol. Cell Biol. 2000;20:957–970
  39. Momparler RL, Bouffard DY, Momparler LF, Dionne J, Belanger K, Ayoub J. Pilot: phase I-II study on 5-aza-2′-deoxycytidine (Decitabine) in patients with metastatic lung cancer. Anticancer Drugs. 1997;8:358
  40. Rivard GE, Momparler RL, Demers J, Beniot P, Raymond R, Lin KT, et al. phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia. Leuk. Res. 1981;5:453
  41. Sun SY, Wan H, Yue P, Hong WK, Lotan R. Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition. J. Biol. Chem. 2000;275:17149–17153
  42. Lehmann S, Paul C, Torma H. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells. Clin. Cancer Res. 2001;7:367–373
  43. Yang Q, Shan L, Yoshimura G, Nakamura M, Nakamura Y, Suzuma T, et al. 5-aza-2′-deoxycytidine induces retinoic acid receptor beta2 gene demethylation, cell cycle arrest and growth inhibition in breast carcinoma cells. Cancer Anticancer Drugs. 2002;22:2753–2756

PII: S0304-3835(05)00062-5

doi: 10.1016/j.canlet.2005.01.012

Cancer Letters
Volume 230, Issue 2 , Pages 271-283 , 18 December 2005

Article Tools

* Image Usage & Resolution